-
Product Insights
Lupoli – Merrimack Street Mixed-Use Complex – Massachusetts
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lupoli - Merrimack Street Mixed-Use Complex - Massachusetts report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
LeCesse Dev Corp – Slate at Merrimack – New Hampshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our LeCesse Dev Corp - Slate at Merrimack - New Hampshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Monahan Co – Merrimack Park Place – New Hampshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Monahan Co - Merrimack Park Place - New Hampshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Company Profile
![]()
Merrimack Pharmaceuticals Inc – Company Profile
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical-stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. It's first commercial product was Onivyde (irinotecan liposome injection) a liposomal formulation for treating advanced pancreatic cancer patients. Merrimack is entitled to receive milestone payments related to sale of Onivyde and MM-436 to Ipsen SA. Merrimack is headquartered in Cambridge, Massachusetts, the US.
Add to Basket -
Company Profile
![]()
Elbit Systems Of America LLC – Company Profile
Elbit Systems Of America LLC (Elbit), a subsidiary of Elbit Systems Ltd is an aerospace products and solution provider. The company operates in the business activities such as defence, commercial aviation, homeland security and sustainment and support. Its commercial aviation segment offers air data products, head up display, cabin pressurization system, cockpit instrumentation, enhanced flight vision system, general aviation vision system and spare parts. Elbit defense segment provides airborne solutions, land and C4I solutions, sensor and electro-optic solutions, services and...
Add to Basket -
Track & Monitor
![]()
Chemotherapy in Pharmaceuticals: Platinum-based cancer drug compositions
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Company Profile
![]()
PC Connection Inc – Company Profile
PC Connection Inc (PC Connection) is a provider of information technology (IT) related products and services. The company markets and distributes hardware and peripherals, networking products, accessories, and software from various manufacturers such as Dell, Lenovo, Cisco Systems, Hewlett-Packard, Apple, Microsoft, and VMware. Its product portfolio comprises cables and adapters, computer parts, monitor and projectors, printers and supplies, servers, accessories, and storage devices. The company markets products through its own sites connection.com, and macconnection.com. PC Connection offers cloud solutions and...
Add to Basket -
Track & Monitor
![]()
Immuno-oncology in Pharmaceuticals: Tumour antibody serum compositions
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Acquired Gene or Chromosome Alterations comprise of reagents employed for genetic testing to detect cancer-causing/ related alterations, such as k-ras. It is used to detect BRCA 1+2, Telomerase, and HER-2/neu (human epidermal growth factor receptor 2) also. The Acquired Gene pipeline market research report provides comprehensive information about the Acquired Gene pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Sector Analysis
Pancreatic Cancer – Opportunity Analysis and Forecasts to 2029
Pancreatic cancer is currently the fourth leading cause of cancer-related deaths in the United States, following lung cancer and breast cancer and seventh leading cause of cancer related deaths worldwide with 432,242 related deaths being reported in 2018. Pancreatic adenocarcinoma (PDAC), classified as an exocrine pancreatic cancer, is considered to be the most common type of pancreatic cancer, accounting for 80% of all pancreatic cancer diagnoses. The treatment paradigm for pancreatic cancer is predominantly composed of chemotherapies, most notably FOLFIRINOX...
-
Product Insights
Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Colorectal Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Product Insights
Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2025
Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted...
-
Product Insights
Thymic Carcinoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and an increase in deal values in January 2017. The industry reported 332 deals worth USD54.9 billion in January 2017, compared to 344 deals worth USD29.1 billion in December 2016. The oncology therapeutics market remained at the top in deal activity in January 2017 with 120 deals. In second place, central nervous system therapeutics market reported 65 deals. Licensing agreements in pharmaceutical and healthcare industry registered an...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.